Featured

Case Study: Guiding Competitive Positioning for a Preclinical Asset

Competitive intelligence case study from Brass Tacks Health for client seeking optimal indication for their clinical development strategy

Case Study: Guiding Potency Assay Development

Competitive intelligence case study from Brass Tacks Health for client navigating FDA approval

Case Study: Guiding Patient Selection for an Early-Stage Therapy

Competitive intelligence case study from Brass Tacks Health for client seeking optimal patient population to target

Case Study: Guiding Target Selection

Competitive intelligence case study from Brass Tacks Health for client developing competitive readiness plan

Case Study: Guiding a Go/No-Go Decision for a Bispecific in Phase 1

Competitive intelligence case study from Brass Tacks Health for client making go/no-go decision for a new therapy

Case Study: Informing Go-to-Market Strategy for a Targeted Therapy Close to Launch

Competitive intelligence case study from Brass Tacks Health for client developing go-to-market strategy in non-small cell lung cancer, NSCLC

Case Study: Steering Competitive Positioning for a Cell Therapy in Phase 1

Competitive intelligence case study from Brass Tacks Health for client conducting product planning in non-Hodgkin Lymphoma subtype, diffuse large B cell lymphoma (DLBCL)

Brass Tacks featured in Health Reporter

Understanding how a drug or therapy affects a variety of demographic groups is essential to ensuring that the product is safe and effective for everyone. However, the industry still struggles to include a broader range of people in clinical trials.

Why drug developers that win the race to recruit more diverse patient populations to clinical trials will be the market leaders of the future

Are you tracking best practices in recruiting diverse patient populations as part of your clinical readiness strategy? Are health equity implications part of your routine Key Intelligence Questions?

To learn more, check out this article in Forbes from Brass Tacks' Principal Eileen Faucher on how drug developers that compete in these areas will be the market leaders in our increasingly diverse America.

Why We Need to Invest in Women Leading Cancer Research

Listen to a Conversation with Dr. Nora Disis, Founder and Director of the Cancer Vaccine Institute, about why we need more women leading cancer research, what specific challenges women face and what strategies we can use to accelerate our careers.

Case Study: Insights into Research and Development in China

As the world’s second-largest healthcare market, China offers drug developers the opportunity to tap into a large, concentrated patient base, lower costs of manufacturing and a potentially less stringent regulatory landscape. Listen to Brass Tacks Analyst Aurora Chen share an example of how we recently guided one biopharma client in developing their competitive readiness strategy in China

What’s a War Game and Why Can It Fall Short?

A War Game is a scenario-planning, role-playing workshop. It typically involves ~40 stakeholders from across the company. Learn three ways to conduct this exercise so it accesses the level of significant insights that can only come from bringing together diverse points of view.

Investing in Women Leading Cancer Research

What is it like to move from academic research to pharma and then biotech? What are the career choices for scientists looking to transition into industry? And how does the culture of each enable a sustainable career path for women? Join us in a recorded conversation with Brass Tacks Founder Eileen Faucher and Dr. Julia Sable.

Brass Tacks founder Eileen Faucher launched her career as a computational chemist, where she learned how much inherent bias can impact the outcome of scientific investigation.

Brass Tacks Health provides biotech and pharma companies with the market insights they need to develop more clinically meaningful therapies for more patients.

“How do you pronounce that?”

Almost every day, we’re asked how to pronounce the complicated name of some new therapy.

So we started this free audio library so we can all have a place to brush up on our pronunciations before our next big presentation or conversation.

Check Out Our "How Do You Pronounce That?” Library →

Connect with us

“How do you pronounce that?”

Almost every day, we’re asked how to pronounce the complicated name of some new therapy.

Let’s talk about where today’s standard of care is headed